JPRN-UMIN000006065已完成未知
Phase II study of TS-1 + CPT-11 for squamous cell lung cancer previously treated with platinum - TS-1+CPT-11 for platinum-resistant squamous cell lung cancer
orth Japan Lung Cancer Group0 个研究点目标入组 30 人开始时间: 2011年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. With obvious interstitial pneumonitis 2. With active other malignancies 3. With massive effusion required tube drainage 4. With severe comorbidities 5. With symptomatic brain metastasis 6. With other conditions that is considered inappropriate for the study by an attending physician
研究者
相似试验
已完成
2 期
Phase II study of a combination of CPT-11 and S-1 and Panitumumab in patients with KRAS wild-type metastatic colon cancer.KRAS wild-type metastatic colon cancer.JPRN-UMIN000005368iigata Colorectal cancer Chemotherapy Study Group (NCCSG)25
已完成
2 期
Phase II study of a combination of CPT-11 and S-1 and bevacizumab in patients with metastatic colon cancer.metastatic colorectal cancerJPRN-UMIN000001631iigata Colorectal cancer Chemotherapy Study Group (NCCSG)35
招募中
2 期
Phase II study of TS-1+CPT-11+BV followed by TS-1+L-OHP+BV in unresectable advanced colorectal cancer with RAS mutatioColorectal cancerJPRN-UMIN000014892iigata Colorectal Cancer Study Group50
已完成
不适用
Phase II study of Combination of CPT-11 and S-1 for Advanced Non-Small-cell lung cancerPreviously untreated stageIIIB/IV NSCLCJPRN-C000000415West Japan Oncology Group55
已完成
1 期
Phase I/II trial of CPT-11 + S-1 combination therapy for patients with previously treated non-small cell lung canceron-small cell lung cancerJPRN-UMIN000001960Keio University School of Medicine Division of Pulmonary Medicine36